The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children

Recruiting in Palo Alto (17 mi)

Overseen byAmy Armstrong, M.D.

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Washington University School of Medicine

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial uses a special scale to measure how much nausea and vomiting children with cancer experience during chemotherapy. The goal is to help doctors give the right anti-nausea medications to make the children feel better.

Research Team

Amy Armstrong, M.D.

Principal Investigator

Washington University School of Medicine

Eligibility Criteria

Inclusion Criteria

Patients diagnosed with cancer of any kind.

Patients receiving inpatient chemotherapy at SLCH on the general pediatric oncology service

Patients admitted for a course of inpatient chemotherapy scheduled to last at least 24 hours and but no more than 7 days.

See 3 more

Treatment Details

Interventions

Baxter Retching Faces (BARF) scale (Behavioral Intervention)

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: BARF scaleExperimental Treatment1 Intervention

* Nursing staff (which may include patient technicians and nursing assistants) will use the scale to assess the patient's nausea for the entire duration of the admission. These assessments will take place in conjunction with vital sign monitoring, every 4 hours. The associated script will be read while the laminated scale is shown to the patient. * The nurse will then log the patient's response in the patient's electronic medical record

Group II: No interventionActive Control1 Intervention

-Patients in the control group will proceed with their inpatient chemotherapy admissions without any interventions. These admissions will take place prior to the admissions of the experimental group, so as not to bias providers.